Endovia Receives FDA Minor Use Designation for Canine Cancer Pain Treatment

Filing content

Endovia Health Sciences announced that CannEpil® has been designated for minor use by the FDA for canine bone cancer pain, establishing a pathway for conditional approval. A pre-submission conference with the FDA is scheduled for November 19.